Moylan S - Search Results

1

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness.

Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O'Neil A, Davey CG, Sanna L, Maes M. Berk M, et al. Among authors: moylan s. BMC Med. 2013 Mar 18;11:74. doi: 10.1186/1741-7015-11-74. BMC Med. 2013. PMID: 23506529 Free PMC article. Review.

2

The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.

Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M. Moylan S, et al. J Clin Psychopharmacol. 2011 Oct;31(5):647-52. doi: 10.1097/JCP.0b013e31822d0012. J Clin Psychopharmacol. 2011. PMID: 21869686

3

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, Bassett DL, Lyndon B, Mitchell PB, Parker G, Fitzgerald PB, Udina M, Singh A, Moylan S, Giorlando F, Doughty C, Davey CG, Theodoros M, Berk M. Dodd S, et al. Among authors: moylan s. Aust N Z J Psychiatry. 2011 Sep;45(9):712-25. doi: 10.3109/00048674.2011.595686. Aust N Z J Psychiatry. 2011. PMID: 21888608 Free PMC article. Review.

4

Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale.

Berk M, Berk L, Udina M, Moylan S, Stafford L, Hallam K, Goldstone S, McGorry PD. Berk M, et al. Among authors: moylan s. Aust N Z J Psychiatry. 2012 Feb;46(2):92-9. doi: 10.1177/0004867411432072. Aust N Z J Psychiatry. 2012. PMID: 22311525 Review.

5

The role of alprazolam for the treatment of panic disorder in Australia.

Moylan S, Giorlando F, Nordfjærn T, Berk M. Moylan S, et al. Aust N Z J Psychiatry. 2012 Mar;46(3):212-24. doi: 10.1177/0004867411432074. Epub 2012 Jan 5. Aust N Z J Psychiatry. 2012. PMID: 22391278 Review.

6

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.

Moylan S, Maes M, Wray NR, Berk M. Moylan S, et al. Mol Psychiatry. 2013 May;18(5):595-606. doi: 10.1038/mp.2012.33. Epub 2012 Apr 24. Mol Psychiatry. 2013. PMID: 22525486 Review.

7

Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.

Sarris J, Moylan S, Camfield DA, Pase MP, Mischoulon D, Berk M, Jacka FN, Schweitzer I. Sarris J, et al. Among authors: moylan s. Evid Based Complement Alternat Med. 2012;2012:809653. doi: 10.1155/2012/809653. Epub 2012 Aug 27. Evid Based Complement Alternat Med. 2012. PMID: 22969831 Free PMC article.

8

Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies.

Moylan S, Jacka FN, Pasco JA, Berk M. Moylan S, et al. BMC Med. 2012 Oct 19;10:123. doi: 10.1186/1741-7015-10-123. BMC Med. 2012. PMID: 23083451 Free PMC article. Review.

9

Putative neuroprotective agents in neuropsychiatric disorders.

Dodd S, Maes M, Anderson G, Dean OM, Moylan S, Berk M. Dodd S, et al. Among authors: moylan s. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:135-45. doi: 10.1016/j.pnpbp.2012.11.007. Epub 2012 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23178231 Review.

10

Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours.

Moylan S, Eyre HA, Maes M, Baune BT, Jacka FN, Berk M. Moylan S, et al. Neurosci Biobehav Rev. 2013 May;37(4):573-84. doi: 10.1016/j.neubiorev.2013.02.003. Epub 2013 Feb 13. Neurosci Biobehav Rev. 2013. PMID: 23415701 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters